A0851 Treatment outcomes of enfortumab vedotin plus pembrolizumab in lymph node–positive urothelial carcinoma patients fit for cystectomy: Real-world data from an enfortumab registry

European Urology 2026

View at publisher
Authors: Fratta M.R. Hassler-Di, Johanna Krauter, Karl Mayrhofer, J. Franke, C. Krallinger, Dominik Vais, M. Pallauf, D. Kiesl, J. Pfuner, A. Terbuch, M. Mayr, A. Banner
+10 more Stefan Aufderklamm, C. Wiesinger, Josef Mühlmann, S. Vallet, Franz Stoiber, Hossein Taghizadeh, R. Pichler, H. Fajkovic, Shahrokh François Shariat, Dora Niedersuess‐Beke
DOI: 10.1016/s0302-2838(26)00892-4
Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Urinary Bladder and Prostate Research

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S2
Publication date
13 February 2026
Language
EN